Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|January 17, 2014

Agilent Technologies, Picometrics Technologies to Offer CE–LIF–MS Systems

Combined technologies from Agilent Technologies and Picometrics Technologies are designed for large–molecule analysis.

Agilent Technologies has signed a co-marketing agreement with Picometrics Technologies offer combined solutions for capillary electrophoresis (CE), laser induced fluorescence (LIF) detection, and mass spectrometry (MS).

A number of Agilent products can be combined with Picometrics ZETALIF LED and ZETALIF LASER instruments, including Agilent’s Capillary Electrophoresis and CE/MS technologies, as well as HPLC/UHPLC solutions.

The platform is suited for the research and development of complex large-molecule biopharmaceutical compounds, the companies report.


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.